Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. John Evans$1.8B
Market Cap • 25/04/20242017
(há 7 anos)
2020
(4 years ago)
NASDAQ
Listagem
Cambridge
Sede • Massachusetts507
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
BEAMSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.